Taipei Exchange - Delayed Quote TWD

Neith Corporation (6236.TWO)

27.80
0.00
(0.00%)
At close: May 23 at 1:23:14 PM GMT+8
Loading Chart for 6236.TWO
  • Previous Close 27.80
  • Open 27.60
  • Bid --
  • Ask 30.00 x --
  • Day's Range 27.60 - 27.80
  • 52 Week Range 23.90 - 37.15
  • Volume 6,000
  • Avg. Volume 704
  • Market Cap (intraday) 1.158B
  • Beta (5Y Monthly) 0.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.07
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also provides genetic testing services. In addition, the company offers energy and dual-purpose mattresses, energy masks, energy silicon gel necklaces, energy waistbands, energy heating stones, massage rods, and water purifiers, as well as Ganbanyoku, an energy stone spa bed. Further, it provides beauty care products, such as cell regeneration and rejuvenation series skin care products; home energy products; and microcontrollers and peripherals. The company was formerly known as Come True Biomedical Inc. Neith Corporation was incorporated in 1997 and is headquartered in Taichung, Taiwan.

www.neithcorp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6236.TWO

View More

Performance Overview: 6236.TWO

Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6236.TWO
7.02%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.33%

1-Year Return

6236.TWO
19.42%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
1.46%

3-Year Return

6236.TWO
46.32%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
31.24%

5-Year Return

6236.TWO
285.58%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
95.09%

Compare To: 6236.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6236.TWO

View More

Valuation Measures

Annual
As of 5/29/2025
  • Market Cap

    1.16B

  • Enterprise Value

    1.03B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    23.71

  • Price/Book (mrq)

    7.40

  • Enterprise Value/Revenue

    21.35

  • Enterprise Value/EBITDA

    578.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.02%

  • Return on Assets (ttm)

    -3.70%

  • Return on Equity (ttm)

    -1.81%

  • Revenue (ttm)

    48.28M

  • Net Income Avi to Common (ttm)

    -2.91M

  • Diluted EPS (ttm)

    -0.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    136.4M

  • Total Debt/Equity (mrq)

    5.88%

  • Levered Free Cash Flow (ttm)

    -9.16M

Research Analysis: 6236.TWO

View More

Company Insights: 6236.TWO

Research Reports: 6236.TWO

View More

People Also Watch